1. Home
  2. SHLT vs CLGN Comparison

SHLT vs CLGN Comparison

Compare SHLT & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHLT
  • CLGN
  • Stock Information
  • Founded
  • SHLT 1987
  • CLGN 2004
  • Country
  • SHLT Israel
  • CLGN Israel
  • Employees
  • SHLT N/A
  • CLGN N/A
  • Industry
  • SHLT Business Services
  • CLGN Industrial Specialties
  • Sector
  • SHLT Consumer Discretionary
  • CLGN Health Care
  • Exchange
  • SHLT Nasdaq
  • CLGN Nasdaq
  • Market Cap
  • SHLT 49.7M
  • CLGN 51.3M
  • IPO Year
  • SHLT N/A
  • CLGN N/A
  • Fundamental
  • Price
  • SHLT $3.02
  • CLGN $3.77
  • Analyst Decision
  • SHLT Strong Buy
  • CLGN Strong Buy
  • Analyst Count
  • SHLT 1
  • CLGN 2
  • Target Price
  • SHLT $11.00
  • CLGN $12.50
  • AVG Volume (30 Days)
  • SHLT 57.1K
  • CLGN 13.5K
  • Earning Date
  • SHLT 09-26-2024
  • CLGN 11-27-2024
  • Dividend Yield
  • SHLT N/A
  • CLGN N/A
  • EPS Growth
  • SHLT N/A
  • CLGN N/A
  • EPS
  • SHLT N/A
  • CLGN N/A
  • Revenue
  • SHLT $55,939,000.00
  • CLGN $650,000.00
  • Revenue This Year
  • SHLT N/A
  • CLGN N/A
  • Revenue Next Year
  • SHLT N/A
  • CLGN $692.59
  • P/E Ratio
  • SHLT N/A
  • CLGN N/A
  • Revenue Growth
  • SHLT N/A
  • CLGN N/A
  • 52 Week Low
  • SHLT $2.54
  • CLGN $3.31
  • 52 Week High
  • SHLT $9.00
  • CLGN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • SHLT 51.63
  • CLGN 34.26
  • Support Level
  • SHLT $2.56
  • CLGN $3.60
  • Resistance Level
  • SHLT $3.87
  • CLGN $4.17
  • Average True Range (ATR)
  • SHLT 0.28
  • CLGN 0.19
  • MACD
  • SHLT 0.04
  • CLGN -0.05
  • Stochastic Oscillator
  • SHLT 35.18
  • CLGN 2.26

About SHLT SHL Telemedicine Ltd

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: